Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend) |
Evidence[PMID] |
FYN |
FYN proto-oncogene, Src family tyrosine kinase |
6q21 |
1(1/0/0)
|
IBA; TAS
|
P2RX7 |
purinergic receptor P2X, ligand gated ion channel, 7 |
12q24 |
9(2/7/0)
|
TAS
|
TLR4 |
toll-like receptor 4 |
9q33.1 |
1(1/0/0)
|
TAS[15356140]
|
TNRC6B |
trinucleotide repeat containing 6B |
22q13 |
1(1/0/0)
|
TAS
|
BCL2 |
B-cell CLL/lymphoma 2 |
18q21.3 |
2(0/2/0)
|
TAS
|
GSK3B |
glycogen synthase kinase 3 beta |
3q13.3 |
8(0/8/0)
|
TAS
|
PLA2G6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
22q13.1 |
2(1/1/0)
|
TAS
|
TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
6q25.1 |
1(0/0/1)
|
TAS
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
7q22 |
1(0/0/1)
|
TAS[17290298]
|
PRKAR1A |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
17q24.2 |
1(1/0/0)
|
TAS
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
14q32.33 |
3(3/0/0)
|
TAS
|
TRIM26 |
tripartite motif containing 26 |
6p21.3 |
2(2/0/0)
|
IDA[18248090]
|
EGFR |
epidermal growth factor receptor |
7p12 |
1(0/0/1)
|
TAS
|
CD36 |
CD36 molecule (thrombospondin receptor) |
7q11.2 |
3(2/1/0)
|
TAS
|
PLCG1 |
phospholipase C, gamma 1 |
20q12-q13.1 |
1(0/1/0)
|
TAS
|
HLA-B |
major histocompatibility complex, class I, B |
6p21.3 |
2(0/1/1)
|
TAS
|
JAK1 |
Janus kinase 1 |
1p32.3-p31.3 |
1(0/1/0)
|
IBA
|
WIPF1 |
WAS/WASL interacting protein family, member 1 |
2q31.2 |
1(0/0/1)
|
TAS
|
ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
4(2/1/1)
|
TAS
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2q33.3-q34 |
2(1/1/0)
|
TAS
|
ADCY9 |
adenylate cyclase 9 |
16p13.3 |
2(1/1/0)
|
TAS
|
ADARB1 |
adenosine deaminase, RNA-specific, B1 |
21q22.3 |
1(0/1/0)
|
IEA
|
CREB1 |
cAMP responsive element binding protein 1 |
2q34 |
2(1/1/0)
|
TAS
|
HSP90B1 |
heat shock protein 90kDa beta (Grp94), member 1 |
12q24.2-q24.3 |
1(1/0/0)
|
TAS
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1p36.1 |
1(0/1/0)
|
TAS
|
PPP2R5D |
protein phosphatase 2, regulatory subunit B', delta |
6p21.1 |
1(1/0/0)
|
TAS
|
CREBBP |
CREB binding protein |
16p13.3 |
1(0/1/0)
|
TAS
|
DUSP6 |
dual specificity phosphatase 6 |
12q22-q23 |
5(3/2/0)
|
TAS
|
ITK |
IL2-inducible T-cell kinase |
5q31-q32 |
1(1/0/0)
|
IBA; TAS
|
MARCO |
macrophage receptor with collagenous structure |
2q14.2 |
1(0/1/0)
|
IEA
|
PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme |
10q22.2 |
2(1/1/0)
|
TAS
|
HSP90AA1 |
heat shock protein 90kDa alpha (cytosolic), class A member 1 |
14q32.33 |
1(1/0/0)
|
TAS
|
PRKCE |
protein kinase C, epsilon |
2p21 |
1(0/1/0)
|
TAS
|
NRG1 |
neuregulin 1 |
8p12 |
15(10/5/0)
|
TAS
|
TNK2 |
tyrosine kinase, non-receptor, 2 |
3q29 |
1(0/1/0)
|
IBA
|
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
11q23 |
1(0/0/1)
|
TAS
|
FOXO3 |
forkhead box O3 |
6q21 |
1(1/0/0)
|
TAS
|
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
1p36 |
1(0/0/1)
|
TAS
|
ADCY2 |
adenylate cyclase 2 (brain) |
5p15.3 |
2(1/1/0)
|
TAS
|
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
17q |
1(0/1/0)
|
TAS
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
7p22 |
1(1/0/0)
|
TAS
|
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
16q24.1 |
1(0/1/0)
|
TAS
|
LRRFIP1 |
leucine rich repeat (in FLII) interacting protein 1 |
2q37.3 |
1(0/1/0)
|
TAS
|
S100B |
S100 calcium binding protein B |
21q22.3 |
2(1/1/0)
|
TAS
|
MAPK10 |
mitogen-activated protein kinase 10 |
4q22-q23 |
1(0/1/0)
|
TAS
|
FGFR2 |
fibroblast growth factor receptor 2 |
10q25.3-q26 |
2(1/1/0)
|
TAS
|
NLRC5 |
NLR family, CARD domain containing 5 |
16q13 |
1(0/1/0)
|
IMP[20434986]; TAS
|
PIK3C3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
18q12.3 |
1(1/0/0)
|
TAS
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
5q13.1 |
1(1/0/0)
|
TAS
|